The Jordan Company, a private equity firm, completed the investment in WEP Clinical, a specialist pharma services company. Financial terms were not disclosed. "We couldn't be more excited to welcome TJC into our next phase of growth. There is a great cultural fit between our organizations, and we share a vision for WEP Clinical's future. TJC's resources and experience will enable us to accelerate our long-term growth plan," Jaswinder Khera, WEP Clinical Co-Founder.